PEG4-H10 dimer and synthesis method thereof
The PEG4-H10 dimer addresses the short half-life and low affinity issues of H10 by forming a dimer structure with glutamic acid and a chelating agent, optimizing synthesis to enhance metabolic time and receptor binding, and improving industrial production efficiency.
Patent Information
- Application Number
- CN202411581266.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-11-07
- Publication Date
- 2024-12-03
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The existing HER2-targeted peptide, H10, has a short half-life in plasma and low affinity for receptors, limiting its localization effect and biological activity.
A PEG4-H10 dimer is synthesized by forming a dimer structure with glutamic acid coupled through a PEG4 chain, where the amino end of glutamic acid is connected to a chelating agent, using a solid phase synthesis method to optimize the process and avoid multiple reaction sites, reducing the need for HPLC purification and lowering equipment requirements.
The PEG4-H10 dimer extends the metabolic time of H10, enhances receptor binding, and improves product yield and purity, making it suitable for industrial production.
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of organic synthesis, and in particular to a PEG4-H10 dimer and a synthesis method thereof. Background Art
[0002] HER2 belongs to the EGFR family and is a transmembrane receptor protein with tyrosine kinase activity. HER2 can participate in cell proliferation, differentiation and apoptosis, and is an important biomarker for breast cancer, gastric cancer and other cancers. HER2 targeted therapy can improve the survival of cancer patients with HER2 overexpression. KLRLEWNR (H10) is one of the small molecule peptides screened out that specifically binds to HER2 in human ovarian cancer cells. Its composition structure is: lysine-leucine-arginine-leucine-glutamic acid-tryptophan-asparagine-arginine, and the structural formula is as follows:
[0003] Since the H10 short-chain peptide is rapidly metabolized, has a short half-life in plasma, and has a low affinity for receptors, its localization effect and biological activity are not very ideal. Summary of the invention
[0004] The purpose of the present invention is to provide a PEG4-H10 dimer and a synthesis method thereof.
[0005] To achieve the above purpose, the technical solution provided by the present invention is: A PEG4-H10 dimer has a structural formula of chelating agent-PEG4-Glu(RK)2, wherein a connecting skeleton is formed by glutamic acid and a PEG4 chain; two carboxyl ends of glutamic acid are respectively coupled with one H10 through a PEG4 chain, so that glutamic acid is coupled with two H10s to form a dimer; and the amino end of glutamic acid is coupled with the chelating agent through a PEG4 chain.
[0006] The chelating agent is selected from HYNIC, MAG3, DOTA, NOTA or one of their derivatives.
[0007] A method for synthesizing a PEG4-H10 dimer comprises the following steps: Step (1): First, the following resin structure is obtained by solid phase synthesis: CTC-Lys(Boc)-Leu-Arg(Pbf)-Leu-Glu(OtBu)-Trp(Boc)-Asn(Trt)-Arg(Pbf)-PEG4-NH2 resin, which is represented by CTC-RK; Step (2): Fmoc-Glu-OH and a condensing agent used to activate the two carboxyl groups in Fmoc-Glu-OH are subjected to a dimerization reaction with the CTC-RK obtained in step (1) to obtain the following resin structure: [CTC-Lys(Boc)-Leu-Arg(Pbf)-Leu-Glu(OtBu)-Trp(Boc)-Asn(Trt)-Arg(Pbf)-PEG4-NH]2Glu resin, which is represented by CTC-E(RK)2; Step (3): After the dimerization reaction is completed, the Fmoc group of the product CTC-E(RK)2 is removed, and Fmoc-PEG4-propionic acid and a chelating agent are further coupled by a solid phase synthesis method to obtain the following resin structure: [CTC-Lys(Boc)-Leu-Arg(Pbf)-Leu-Glu(OtBu)-Trp(Boc)-Asn(Trt)-Arg(Pbf)-PEG4-NH]2Glu-PEG4-chelating agent resin, which is represented by CTC-chelating agent-PE(RK)2; Step (4): Finally, the target compound chelator-PEG4-Glu(RK)2 is obtained by cleavage of the peptide from CTC-chelator-PE(RK)2.
[0008] In order to optimize the above technical solutions, the specific limitations adopted also include: Step (1) The solid phase synthesis method for preparing CTC-RK is to add HBTU, DIPEA and a to-be-coupled substance to CTC-Lys(Boc), wherein the to-be-coupled substance is a protected amino acid and Fmoc-PEG4-propionic acid, and sequentially couple the protected amino acid and Fmoc-PEG4-propionic acid, and perform a de-Fmoc treatment for each coupling.
[0009] The protected amino acids include Fmoc-Leu-OH, Fmoc-Arg(Pbf)-OH, Fmoc-Leu-OH, Fmoc-Glu(OtBu)-OH, Fmoc-Trp(Boc)-OH, Fmoc-Asn(Trt)-OH and Fmoc-Arg(Pbf)-OH, and the protected amino acids are coupled in the above order, and finally Fmoc-PEG4-propionic acid is coupled; the reaction molar ratio of CTC-Lys(Boc), protected amino acids or Fmoc-PEG4-propionic acid, HBTU and DIPEA is 1.0:3.0:3.0:3.0.
[0010] The synthesis method for preparing CTC-E(RK)2 in step (2) is to add Fmoc-Glu-OH, HATU, HOAt and DIPEA to the CTC-RK obtained in step (1) for reaction, and then perform a de-Fmoc treatment.
[0011] The reaction molar ratio of CTC-Lys(Boc) in step (1) and Fmoc-Glu-OH, HATU, HOAt, and DIPEA added in step (2) is 1.0:0.5:1.0:1.2:2.0.
[0012] The solid phase synthesis method for preparing CTC-chelating agent-PE(RK)2 in step (3) is to add HATU, HOAt, DIPEA and a coupling substance to be coupled to CTC-E(RK)2 obtained in step (2), wherein the coupling substance to be coupled is Fmoc-PEG4-propionic acid and a chelating agent, and sequentially couple Fmoc-PEG4-propionic acid and a chelating agent, and perform a de-Fmoc treatment for each coupling.
[0013] The reaction molar ratio of CTC-Lys(Boc) in step (1) and Fmoc-PEG4-propionic acid or chelating agent, HATU, HOAt, DIPEA added in step (3) is 1.0:1.5:1.5:1.8:3.0.
[0014] In step (4), the CTC resin lysis solution uses 95% TFA lysis solution, which is prepared by TFA:TIPS:H2O=95:2.5:2.5 (v / v), mixed evenly, and frozen to 5±5°C.
[0015] Compared with the prior art, the present invention has the following beneficial effects: The present invention provides a PEG4-H10 dimer. The metabolism time of H10 can be prolonged by preparing H10 into the form of the PEG4-H10 dimer.
[0016] The invention provides a method for synthesizing the PEG4-H10 dimer. The method avoids multiple reaction sites existing in a linear polypeptide chain during liquid phase synthesis, overcomes the problem that the linear polypeptide chain ends carry carboxyl groups after being cut off from a resin, and makes dimerization between relatively difficult macromolecules relatively easy.
[0017] The synthetic route of the invention has short synthetic steps, a simple and efficient reaction process, avoids the need for multiple HPLC preparation and purification steps, has low equipment requirements, reduces raw material costs, has high product yield and purity, and is easy for industrial production. DETAILED DESCRIPTION
[0018] The above contents of the present invention are further described in detail below in the form of embodiments, but this should not be understood as the scope of the above subject matter of the present invention being limited to the following embodiments, and all technologies realized based on the above contents of the present invention belong to the scope of the present invention.
[0019] The experimental methods used in the following examples are all conventional methods unless otherwise specified, and the reagents, methods and equipment used are all conventional reagents, methods and equipment in the technical field unless otherwise specified.
[0020] Some of the terms in the present invention are explained as follows: RK is the abbreviation of PEG4-H10.
[0021] The structure of PEG4-H10 is as follows:
[0022] In HPE(RK)2, MPE(RK)2, DPE(RK)2 and NPE(RK)2, P is the abbreviation of PEG4, H is the abbreviation of chelating agent HYNIC, M is the abbreviation of chelating agent MAG3, D is the abbreviation of chelating agent DOTA, N is the abbreviation of chelating agent NOTA, and E is the abbreviation of glutamic acid, namely: HPE(RK)2 corresponds to: HYNIC-PEG4-Glu(PEG4-H10)2; MPE(RK)2 corresponds to: MAG3-PEG4-Glu(PEG4-H10)2; DPE(RK)2 corresponds to: DOTA-PEG4-Glu(PEG4-H10)2; NPE(RK)2 corresponds to: NOTA-PEG4-Glu(PEG4-H10)2.
[0023] Solvents and reagents: Table 1 Abbreviations
[0024] In order to increase the metabolic time of H10 in the body, the present application prepared a PEG4-H10 dimer and studied and improved its preparation method.
[0025] The present invention provides a PEG4-H10 dimer that can increase the metabolic time of H10 in vivo. In order to increase the water solubility of H10, a PEG fragment is inserted between H10 and Glu, and between a chelating agent and Glu; in order to extend the metabolic time of H10 in vivo, Glu is introduced to combine with PEG4-H10 (abbreviated as RK) to form a dimer. The dimer structure of H10 increases the site for binding with the receptor, and can more effectively bind to the receptor, thereby extending the metabolic time of H10. The principle and method of extending the metabolic time are well-known technologies in the art, and will not be described in detail herein.
[0026] The structural formula of the PEG4-H10 dimer provided in the present application is chelator-PEG4-Glu(RK)2, in which a linker skeleton is formed by glutamic acid and a PEG4 chain; the two carboxyl ends of glutamic acid are respectively coupled to one H10 through a PEG4 chain, so that glutamic acid is coupled to two H10s to form a dimer; the amino end of glutamic acid is coupled to the chelator through a PEG4 chain.
[0027] The chelating agent can be selected from common chelating agents, including but not limited to HYNIC, MAG3, DOTA, NOTA or one of their derivatives.
[0028] The structural formula of the chelating agent PEG4-Glu (RK) 2 provided in the present application is as follows:
[0029] The structural formula is as follows:
[0030] This application studies and improves the preparation method of chelating agent-PEG4-Glu(RK)2: (i) In one preparation method, PEG4-H10 (fully protected) is first used to prepare E(RK)2; wherein, fully protected means that all active sites in the middle are protected except for the two ends.
[0031] The structural formula of PEG4-H10 (fully protected) is as follows:
[0032] The reaction formula for preparing E(RK)2 is as follows:
[0033] Fmoc-Glu-OH and HOSu first form a double activated ester with HOSu in the presence of a carbodiimide condensing agent (DIC, DCC, EDC, HCl, etc.), and the double activated ester is coupled with PEG4-H10 (fully protected) under alkaline conditions of pH = 8-9 to form a dimer.
[0034] During the experiment, it was found that the coupling reaction of Fmoc-Glu-diactivated ester and PEG4-H10 (fully protected) could not proceed, and the reaction did not improve when Boc-Glu-OH replaced Fmoc-Glu-OH. This may be because the molecular weight of PEG4-H10 (fully protected) is 2364.93, which has a large steric hindrance. Dimerizing these two large molecules on the two carboxyl groups of Glu cannot achieve a good effect even with a more active condensing agent.
[0035] (ii) In another preparation method, PEG4-H10(Dde) is firstly used to undergo a dimerization, and then a chelating agent - PEG4-Glu(PEG4-H10) is prepared by two couplings; wherein, (Dde) indicates that the peptide chain has only one Dde protecting group.
[0036] The structural formula of PEG4-H10(Dde) is as follows:
[0037] Taking the preparation of HYNIC-PEG4-Glu(PEG4-H10)2 as an example, the reaction formula is as follows:
[0038]
[0039] After using PEG4-H10(Dde) instead of PEG4-H10(fully protected), Fmoc-Glu-diactivated ester can undergo coupling reaction with PEG4-H10(Dde) under DIPEA conditions. The purity of the crude dimer E[RK(Dde)]2 obtained after removing Fmoc is 20-30%, and it needs to be prepared and purified by HPLC before entering the next reaction; in the subsequent 2 steps of coupling reaction of PEG4 activated ester and chelating agent HYNIC activated ester, since only the amino group of the terminal Lys of PEG4-H10(Dde) has a Dde protecting group, and the active amino groups on the other chains are not protected, the purity of the crude intermediate PE[RK(Dde)]2 is 60-70%, and it also needs to be prepared and purified by HPLC before entering the next reaction; after finally coupling Fmoc-HYNIC activated ester, the purity of the crude HPE(RK)2 obtained after removing the Fmoc protecting group and the Dde protecting group is 70-80%.
[0040] This route can obtain products with a total yield of about 5% and a product purity of >98%. This route has complicated processes and the resulting products are expensive, making it unsuitable for large-scale industrial production. In addition, Fmoc-Lys(Dde)-OH is inevitably required, and the price of Fmoc-Lys(Dde)-OH is relatively high, at 200-250 yuan / g, which is about 20 times that of Fmoc-Lys(Boc)-OH.
[0041] The method is specifically described in Comparative Examples 1-4.
[0042] (III) In another preparation method, considering reducing the reaction steps, Glu, PEG4 and chelating agent are prepared as a whole fragment. The fragment can be prepared by conventional solid phase synthesis using CTC-Glu (OtBu) resin, or by two liquid phase couplings in the presence of HOSu and DIC, HATU and DIPEA, or PyBop and HOBt and DIPEA. Then, the fragment chelating agent - PEG4-Glu-OH is made into a double activated ester and coupled with PEG4-H10 (Dde) to obtain the product.
[0043] Taking the preparation of HYNIC-PEG4-Glu(PEG4-H10)2 as an example, the reaction formula is as follows:
[0044]
[0045] Fmoc-HYNIC-PEG4-Glu-OH can also be made into a double activated ester under the conditions of HOSu and DIC, but the amount of DIC needs to be increased to 6.0eq, and the reaction time needs to be 16-18h. The purity of the obtained activated ester Fmoc-HYNIC-PEG4-Glu-Osu is 70-80%. The experiment found that the activated ester can be prepared and purified by HPLC, but the activated ester prepared and purified by HPLC cannot dimerize with PEG4-H10(Dde), while the crude activated ester without purification can dimerize with PEG4-H10(Dde). The crude HPE(RK)2 obtained after removing the Fmoc protecting group and the Dde protecting group has a purity of 20-30%. This situation may be related to the particularity of double coupling. The introduction of two large molecular weight polypeptides at the same time not only requires the purity of the reaction substrate, but also the spatial structure of the reaction substrate. If the peptide chain is folded and curled, and the reaction site is masked, then even if the purity of the reaction substrate is very high, coupling cannot be performed.
[0046] Although this route simplifies the process, the purity of the crude product obtained is poor, only 20-30%. After HPLC preparation and purification, the total yield of the product is 10-15%, and the product purity is >95%.
[0047] The method is specifically shown in Comparative Examples 5 and 6.
[0048] (IV) The present invention improves and optimizes the above preparation method and proposes a more effective method: first, solid phase synthesis of CTC-Lys(Boc)-Leu-Arg(Pbf)-Leu-Glu(OtBu)-Trp(Boc)-Asn(Trt)-Arg(Pbf)-PEG4-NH2 resin; Fmoc-Glu-OH and a corresponding proportion of a condensing agent are dimerized with the resin, and after completion, the Fmoc group is removed, and Fmoc-PEG4-propionic acid and a chelating agent are coupled, and 95% TFA cutting is performed to obtain the target compound.
[0049] This scheme completely avoids the problem of multiple reaction sites in the dimerization process of the linear 9-peptide [PEG4-H10(Dde)]. Since the carboxyl group of Lys at the end of the peptide chain is connected to the resin and the active sites of the amino acids on the chain are also protected, the two carboxyl groups of Glu and the amino group at the end of the PEG4 chain are the only sites where coupling can occur. A condensing agent with stronger activity (for example: HATU / HOAt / DIPEA) can be selected for dimerization. After the dimerization reaction is completed, the coupling of Fmoc-PEG4-propionic acid and the chelating agent is completed by solid phase synthesis, and the final product chelating agent - PEG4-Glu (PEG4-H10)2 can be obtained by cutting.
[0050] The crude purity of the chelating agent-PEG4-Glu (PEG4-H10) 2 obtained according to the process is 60-70%. After HPLC preparation and purification, a product with a purity of more than 98% can be obtained, and the total yield of the product is 40-50%.
[0051] This route has short synthesis steps, a very simple and efficient reaction process, avoids multiple HPLC preparation and purification steps, has low equipment requirements, reduces raw material costs, has high product yield and purity, and is easy for industrial production.
[0052] The method is specifically described in Examples 1-4.
[0053] The present invention is further described in detail below in conjunction with specific embodiments: Comparative Examples 1-4 describe the preparation of the chelating agent -PEG4-Glu(RK)2 by liquid phase, using PEG4-H10(Dde) and adopting the preparation method of dimerization + 2 couplings.
[0054] Comparative Example 1: Preparation of E[RK(Dde)]2 Preparation of crude E[RK(Dde)]2, feed amount: Table 2 Comparative Example 1 Preparation of E[RK(Dde)]2 crude product feed amount
[0055] Process Description: Add Fmoc-Glu-OH, HOSu and 5ml DMF to a 10ml reaction bottle, stir to dissolve, add DIC, and stir the reaction solution at room temperature for 4-5h. Filter to remove the reaction by-products to obtain a DMF solution of Fmoc-Glu-Osu, which is directly used for the next step without treatment.
[0056] Add PEG4-H10 (Dde) and 50 ml of DMF into a 100 ml reaction bottle, stir to dissolve, add the DMF solution of Fmoc-Glu-Osu, add DIPEA, and stir the reaction solution at room temperature for 2-3 hours.
[0057] 13.8 ml of piperidine was added to the reaction solution, and the reaction solution was stirred and reacted at room temperature for 0.5 h. The reaction solution was added into 500 ml of water, and a white solid precipitated. The solid was filtered, and the filter cake was fully rinsed with ether and dried under vacuum at room temperature to obtain crude E[RK(Dde)]2. The yield of the crude product was 115.39%, and the purity of the crude product was 26.101%.
[0058] Preparation of E[RK(Dde)]2 refined product, feed amount: Table 3 Comparative Example 1 Preparation of E[RK(Dde)]2 Refined Product Feeding Amount
[0059] Purification conditions: Chromatographic column: DEVOTE Dasiogel C18 250mm*100mm, 8μm; Mobile phase: Mobile phase A: 0.1% TFA aqueous solution; Mobile phase B: acetonitrile; Detection wavelength: 365nm; Flow rate: 160ml / min; Purification gradient see Table 4: Table 4 Comparative Example 1 E[RK(Dde)]2 purification gradient
[0060] The purification yield was 17.58% and the product purity was 95.223%.
[0061] Comparative Example 2: Preparation of PE[RK(Dde)]2 Preparation of PE[RK(Dde)]2 crude product, feed amount: Table 5 Comparative Example 2 Preparation of PE[RK(Dde)]2 crude product feed amount
[0062] Process Description: Add Fmoc-PEG4-propionic acid, HOSu, and 2 ml DMF to a 5 ml reaction bottle, stir to dissolve, add DIC, and stir the reaction solution at room temperature for 4-5 hours. Filter to remove the reaction by-products to obtain a DMF solution of Fmoc-PEG4-propionic acid activated ester, which is directly used for the next step without treatment.
[0063] Add E[RK(Dde)]2 and 5 ml DMF to a 10 ml reaction bottle, stir, add DMF solution of Fmoc-PEG4-propionic acid activated ester, add DIPEA, and stir the reaction solution at room temperature for 1-2 h.
[0064] 1.75 ml of piperidine was added to the reaction solution, and the reaction solution was stirred and reacted at room temperature for 15-30 min. The reaction solution was added to 70 ml of water, and a white solid was precipitated. The filter cake was fully rinsed with ether and dried under vacuum at room temperature to obtain a crude PE[RK(Dde)]2 product with a crude yield of 106.82% and a purity of 62.705%.
[0065] Preparation of PE[RK(Dde)]2 refined products, feed amount: Table 6 Comparative Example 2 Preparation of PE [RK (Dde)] 2 Refined Product Feeding Amount
[0066] Purification conditions: Chromatographic column: DEVOTE Dasiogel C18 250mm*50mm, 8μm; Mobile phase: Mobile phase A: 0.1% TFA aqueous solution, Mobile phase B: acetonitrile; Detection wavelength: 365nm; Flow rate: 40ml / min; Purification gradient see Table 7: Table 7 Comparative Example 2 PE[RK(Dde)]2 purification gradient
[0067] Process Description: Dissolution and filtration of crude PE[RK(Dde)]2: The crude PE[RK(Dde)]2 was ultrasonically dissolved with 40 ml of diluent (85% mobile phase A-15% mobile phase B). A 0.22 µm microporous glass fiber filter was placed in the funnel, fully wetted, and the crude PE[RK(Dde)]2 solution was added. A vacuum pump was connected, and the control valve was opened for suction filtration. The filter paper was replaced according to the actual situation. After the last filtration of the crude PE[RK(Dde)]2 solution, 10 ml of diluent was added to the filter for filtration, and the filtrate was combined with the crude PE[RK(Dde)]2 solution.
[0068] Loading: Load the crude PE[RK(Dde)]2 solution; Elution: Perform linear gradient elution according to the purification gradient; Sample collection: Collect the target peak {PE[RK(Dde)]2 retention time is about 31min} in segments, and save the preparation chromatogram; Merge: Merge samples with a purity less than 95.0% into a purer sample; Concentrate: Merge and concentrate the sample fractions with a purity greater than 95.0%; Freeze-dry: Divide the merged target peptide solution into freeze-drying trays, each tray with a thickness of 1.0~1.5 cm; Put the product into the box, lock the box door, quickly freeze the product to below -45℃ and keep it warm for 2 hours, turn on the vacuum pump to evacuate the front box, the vacuum degree is <50Pa, and sublimate according to the following curve: Set the heat transfer oil to rise to -5℃ in 2 hours and keep it for more than 14 hours; Set the heat transfer oil to rise to 25℃ in 2 hours and keep it for more than 6 hours; Release the vacuum, open the vacuum leak valve to release the vacuum in the box to normal pressure. Sampling and packaging: Release the vacuum, open the vacuum leak valve to release the vacuum in the box to normal pressure. Open the box door and quickly take out the freeze-dried plate from the box. Immediately take samples according to the sampling operation procedures after taking out of the box. Transfer the drug into a low-density ethylene bottle for drug packaging, weigh it, label it, seal it, and store it in the freezer. The purification yield is 48.33% and the purity is 97.212%.
[0069] Comparative Examples 3 and 4 describe the preparation of chelating agent-PE(RK)2, and the preparation of HPE(RK)2 and NPE(RK)2 are exemplified as follows: Comparative Example 3: Preparation of HPE(RK)2 Preparation of crude HPE(RK)2, feed amount: Table 8 Comparative Example 3 Preparation of HPE (RK) 2 crude material feed amount
[0070] Process Description: Add Fmoc-HYNIC, HOSu and 1 ml DMF to a 5 ml reaction bottle, stir to dissolve, add DIC, and stir the reaction solution at room temperature for 4-5 hours. Filter to remove the reaction by-products to obtain a DMF solution of Fmoc-HYNIC activated ester, which is directly used for the next step without treatment.
[0071] Add E[RK(Dde)]2 and 5 ml DMF to a 10 ml reaction bottle, stir, add the DMF solution of Fmoc-HYNIC activated ester, add DIPEA, and stir the reaction solution at room temperature for 1-2 h.
[0072] 1.5 ml of piperidine was added to the reaction solution, and the reaction solution was stirred and reacted at room temperature for 15-30 min.
[0073] 155 μl of hydrazine hydrate was added to the reaction solution, and the reaction solution was stirred and reacted at room temperature for 0.5-1.0 h.
[0074] The reaction solution was added into 80 ml of water, and a white solid was precipitated. The solid was filtered, and the filter cake was fully rinsed with ether and dried under vacuum at room temperature to obtain crude HPE(RK)2. The yield of the crude product was 104.80%, and the purity of the crude product was 74.352%.
[0075] Preparation of HPE(RK)2 refined products, feed amount: Table 9 Comparative Example 3 Preparation of HPE (RK) 2 Refined Product Feeding Amount
[0076] Purification conditions: Chromatographic column: DEVOTE Dasiogel C18 250mm*50mm, 8μm; Mobile phase: Mobile phase A: 0.1% TFA aqueous solution; Mobile phase B: acetonitrile; Detection wavelength: 220nm; Flow rate: 40ml / min; Purification gradient see Table 10: Table 10 Comparative Example 3 HPE(RK)2 purification gradient
[0077] Process Description: Dissolve and filter the crude HPE(RK)2: Dissolve the crude HPE(RK)2 with 40ml diluent (85% mobile phase A-15% mobile phase B) by ultrasonic. Place a 0.22µm microporous glass fiber filter in the funnel, fully wet it, add the crude HPE(RK)2 solution, connect the vacuum pump, open the control valve, filter, and replace the filter paper according to the actual situation. After the last filtration of the crude HPE(RK)2 solution, add 10ml of diluent to the filter for filtration, and combine the filtrate with the crude HPE(RK)2 solution.
[0078] Loading: Load the crude HPE(RK)2 solution; Elution: Perform linear gradient elution according to the purification gradient; Sample collection: Collect the target peak in segments [HPE(RK)2 retention time is about 44min] and save the preparation chromatogram; Merge: Merge samples with purity less than 98.0% into pure samples; Concentrate: Merge and concentrate sample fractions with purity greater than 98.0%; Freeze-dry: Dispense the merged target peptide solution into freeze-drying trays, each tray with a thickness of 1.0~1.5 cm; Put the product into the box, lock the box door, quickly freeze the product to below -45℃ and keep it warm for 2 hours, turn on the vacuum pump to evacuate the front box, the vacuum degree is <50Pa, and sublimate according to the following curve: Set the heat transfer oil to -5℃ in 2 hours and keep it for more than 14 hours; Set the heat transfer oil to 25℃ in 2 hours and keep it for more than 6 hours; Release the vacuum, open the vacuum leak valve to release the vacuum in the box to normal pressure. Sampling and packaging: Release the vacuum, open the vacuum leak valve to release the vacuum in the box to normal pressure. Open the box door and quickly take out the freeze-dried plate from the box. Immediately take samples according to the sampling operation procedures after taking out of the box. Transfer the drug into a low-density ethylene bottle for drug packaging, weigh it, label it, seal it, and store it in the freezer. The purification yield is 58.88% and the purity is 98.933%.
[0079] Comparative Example 4: Preparation of NPE(RK)2 Preparation of crude NPE(RK)2, feed amount: Table 11 Feeding amount of crude NPE(RK)2 prepared in Comparative Example 4
[0080] Process description: The process for preparing crude HPE(RK)2 is roughly the same as that for preparing HPE(RK)2 in Comparative Example 3, and crude NPE(RK)2 is obtained with a crude yield of 108.49% and a purity of 73.987%.
[0081] Preparation of refined NPE(RK)2, feed amount: Table 12 Feeding amount for preparing refined NPE(RK)2 in Comparative Example 4
[0082] Purification conditions: Chromatographic column: DEVOTE Dasiogel C18 250mm*50mm, 8μm; Mobile phase: Mobile phase A: 0.1% TFA aqueous solution, Mobile phase B: acetonitrile; Detection wavelength: 220nm; Flow rate: 40ml / min; Purification gradient see Table 13: Table 13 Comparative Example 4 Preparation of NPE (RK) 2 Refined Product Feeding Amount
[0083] Process Description: Dissolve and filter the crude NPE(RK)2: Dissolve the crude NPE(RK)2 with 40ml diluent (90% mobile phase A-10% mobile phase B) by ultrasonic. Place a 0.22µm microporous glass fiber filter in the funnel, fully wet it, add the crude NPE(RK)2 solution, connect the vacuum pump, open the control valve, filter, and replace the filter paper according to the actual situation. After the last filtration of the crude NPE(RK)2 solution, add 10ml of diluent to the filter for filtration, and combine the filtrate with the crude NPE(RK)2 solution.
[0084] Loading: Take the crude NPE(RK)2 solution and load it; elution: perform linear gradient elution according to the purification gradient; sample collection: collect the target peak in segments [the retention time of NPE(RK)2 is about 44min] and save the preparation chromatogram; merging: merge the samples with purity less than 95.0% into a purer sample; concentration: merge and concentrate the sample fractions with purity greater than 95.0%; freeze drying: divide the merged target peptide solution into trays for freeze drying, each tray is 1.0~1.5 cm thick; the product is put into the box, the box door is locked, the product is quickly frozen to below -45℃ and kept warm for 2 hours, the vacuum pump is turned on to evacuate the front box, the vacuum degree is <50Pa, and the temperature is raised and sublimated according to the following curve: set the heat transfer oil to heat up to -5℃ in 2 hours and keep it for more than 14 hours; set the heat transfer oil to heat up to 25℃ in 2 hours and keep it for more than 6 hours; release the vacuum, open the vacuum leak valve to release the vacuum in the box to normal pressure. Sampling and packaging: Release the vacuum, open the vacuum leak valve to release the vacuum in the box to normal pressure. Open the box door and quickly take out the freeze-dried plate from the box. Immediately take samples according to the sampling operation procedures after taking out of the box. Transfer the drug into a low-density ethylene bottle for drug packaging, weigh it, label it, seal it, and store it in the freezer. The purification yield is 57.14% and the purity is 99.322%.
[0085] Comparative Examples 5 and 6 describe the preparation of the chelating agent -PEG4-Glu(RK)2 by liquid phase using PEG4-H10(Dde) by dimerization method.
[0086] Comparative Example 5: Preparation of HPE(RK)2 Preparation of crude HPE(RK)2, the reaction equation is as follows in the above "Taking the preparation of HYNIC-PEG4-Glu(PEG4-H10)2 as an example", feed amount: Table 14 Comparative Example 5 Preparation of HPE (RK) 2 crude product feed amount
[0087] Process Description: Fmoc-HYNIC-PEG4-Glu-OH, HOSu and 10 ml DMF were added to a 50 ml reaction bottle, stirred to dissolve, and DIC was added. The reaction solution was stirred at room temperature for 16-18 hours, filtered, and the reaction by-products were removed to obtain a DMF solution of Fmoc-HYNIC-PEG4-Glu-OSu. 200 ml of pre-cooled ether was added for reflux, filtered, and dried in vacuo at room temperature to obtain Fmoc-HYNIC-PEG4-Glu-Osu with a yield of 104.88%.
[0088] Add PEG4-H10 (Dde) and 50 ml DMF to a 100 ml reaction bottle, stir to dissolve, add Fmoc-HYNIC-PEG4-Glu-OSu, add DIPEA, and stir the reaction solution at room temperature for 2-3 hours.
[0089] 12.5 ml of piperidine was added to the reaction solution, and the reaction solution was stirred and reacted at room temperature for 15-30 min.
[0090] 1.28 ml of hydrazine hydrate was added to the reaction solution, and the reaction solution was stirred and reacted at room temperature for 0.5-1.0 h.
[0091] The reaction solution was added to 500 ml of water to precipitate a white solid, which was filtered and the filter cake was fully rinsed with ether and dried in vacuo at room temperature to obtain a crude HPE(RK)2 product with a crude yield of 108.00% and a purity of 26.304%.
[0092] Preparation of HPE(RK)2 refined products, feed amount: Table 15 Comparative Example 5 Preparation of HPE (RK) 2 Refined Product Feeding Amount
[0093] Process description: The process of preparing HPE(RK)2 refined product is roughly the same as that of preparing HPE(RK)2 in Comparative Example 3. The HPE(RK)2 refined product is obtained with a purification yield of 10.94% and a purity of 96.463%.
[0094] Comparative Example 6: Preparation of MPE(RK)2 Preparation of crude MPE(RK)2, feed amount: Table 16 Comparative Example 6 Preparation of MPE (RK) 2 crude product feed amount
[0095] Process description: The process of preparing crude HPE(RK)2 is roughly the same as that of preparing HPE(RK)2 in Comparative Example 3, and crude MPE(RK)2 is obtained with a crude yield of 102.04% and a purity of 31.537%.
[0096] Preparation of MPE(RK)2 refined product, feed amount: Table 17 Comparative Example 6 Preparation of MPE (RK) 2 Refined Product Feeding Amount
[0097] Purification conditions: Chromatographic column: DEVOTE Dasiogel C18 250mm*100mm, 8μm; Mobile phase: Mobile phase A: 0.1% TFA aqueous solution, Mobile phase B: acetonitrile; Detection wavelength: 220nm; Flow rate: 160ml / min; Purification gradient see Table 18: Table 18 Comparative Example 6 Purification Gradient of MPE(RK)2 Refined Product
[0098] Process Description: Dissolve and filter the crude MPE[RK(Dde)]2: Use 400ml of diluent (90% mobile phase A-10% mobile phase B) to ultrasonically dissolve the crude MPE[RK(Dde)]2; Place a 0.22µm microporous glass fiber filter in the funnel, fully wet it, add the crude MPE[RK(Dde)]2 solution, connect the vacuum pump, open the control valve, filter, and replace the filter paper according to the actual situation. After the last filtration of the crude MPE[RK(Dde)]2 solution, add 100ml of diluent to the filter for filtration, and combine the filtrate with the crude MPE[RK(Dde)]2 solution.
[0099] Loading: Load the crude MPE[RK(Dde)]2 solution; Elution: Perform linear gradient elution according to the purification gradient; Collect samples: collect the target peak (MPE[RK(Dde)]2 retention time is about 46min) in segments and save the preparation chromatogram; merge: merge samples with purity less than 95.0% into pure samples; concentrate: merge and concentrate sample fractions with purity greater than 95.0%; freeze-dry: pack the merged target peptide solution into freeze-drying trays, each tray is 1.0~1.5 cm thick; put the product into the box, lock the box door, quickly freeze the product to below -45℃ and keep it warm for 2 hours, turn on the vacuum pump to evacuate the front box, the vacuum degree is <50Pa, and sublimate according to the following curve: set the heat transfer oil to -5℃ in 2 hours and keep it for more than 14 hours; set the heat transfer oil to 25℃ in 2 hours and keep it for more than 6 hours; release the vacuum, open the vacuum leak valve to release the vacuum in the box to normal pressure.
[0100] Sampling and packaging: Release the vacuum, open the vacuum leak valve to release the vacuum in the box to normal pressure. Open the door and take out the freeze-dried The tray is quickly taken out of the box. Immediately after taking out of the box, sampling is carried out according to the sampling operation procedures. The drug is transferred into a low-density ethylene bottle for drug packaging, weighed, labeled, sealed, and frozen for storage. The purification yield is 12.01% and the purity is 96.124%.
[0101] Examples 1-4 describe the method of using all solid phase synthesis: Chelator-PEG4-Glu(RK)2.
[0102] Example 1: Preparation of HPE(RK)2 Preparation of crude HPE(RK)2, reaction equation:
[0103]
[0104]
[0105] Feeding amount: Table 19 Example 1 Preparation of HPE (RK) 2 crude material amount
[0106] Table 20 Example 1 Preparation of HPE (RK) 2 crude material feed amount II
[0107] Table 21 Example 1 Preparation of HPE (RK) 2 crude material feeding amount three
[0108] Process Description: (1) Washing and swelling Weigh CTC-Lys (Boc) resin, add it to the peptide solid phase synthesis tube, weigh N, N-dimethylformamide (DMF) and add it to the peptide solid phase synthesis tube (the amount of solvent is based on the resin being evenly dispersed in the solvent. Generally, the amount of solvent is 4.0-6.0eq of the amount of resin, the same below), wash twice (N2 bubbling, 1 min each time, and remove after washing); add DMF to the peptide solid phase synthesis tube, bubble N2 for 30 min, and drain the liquid after sufficient swelling; (2) Coupling of Fmoc-Leu-OH Removal of Fmoc group and color development: Add 20% piperidine solution to the peptide solid phase synthesis tube, remove Fmoc twice [N2 bubbling, time (5min, 7min), and drain the liquid after completion], and wash with DMF 6 times (N2 bubbling, 1min each time, and drain after washing); Kaiser method (take a small amount of resin, wash with DMF, add 3-5 drops of ninhydrin solution, heat at 120℃ for 3min, and observe whether color develops) to detect the color change of the resin; Activation, coupling, color development, washing: Based on the synthesis scale N0, weigh the materials according to a certain feed ratio: Fmoc-Leu-OH (3.0eq), HBTU (3.0eq); add them to a beaker, take an appropriate amount of DMF, stir to dissolve, add DIPEA (3.0eq), activate the reaction for 3 minutes, and then add it to the peptide solid phase synthesis tube; room temperature 20-35℃, coupling reaction 0.5~1.0 hour; Kaiser method (take a small amount of resin, wash with DMF, add 3-5 drops of ninhydrin solution, heat at 120°C for 3 minutes; observe whether color is developed to determine whether the reaction is complete; if color is developed, continue coupling for 0.5 hours); The reaction solution was drained and washed with DMF 3 times (N2 bubbling, 1 min each time, and then drained after washing); According to the dosage in the material list, the following 6 amino acid fragments and Fmoc-PEG4-propionic acid fragment were coupled according to the operation in (2) above: (3) Coupling of Fmoc-Arg(Pbf)-OH; (4) Coupling of Fmoc-Leu-OH; (5) Coupling of Fmoc-Glu(OtBu)-OH; (6) Coupling of Fmoc-Trp(Boc)-OH; (7) Coupling of Fmoc-Asn(Trt)-OH; (8) Coupling of Fmoc-Arg(Pbf)-OH; (9) Coupling Fmoc-PEG4-propionic acid; (10) Removal of Fmoc group and color development Add 20% piperidine solution to the peptide solid phase synthesis tube, remove Fmoc twice [N2 bubbling, time (5min, 7min), and drain the liquid after completion], and wash with DMF 6 times (N2 bubbling, 1min each time, and drain after washing); Kaiser method (take a small amount of resin, wash with DMF, add 3-5 drops of ninhydrin solution, heat at 120℃ for 3min, and observe whether color develops) to detect the color change of the resin; (11) Dimerization Based on the synthesis scale N0, weigh the materials according to a certain feed ratio: Fmoc-Glu-OH (0.5eq), HATU (1.0eq), HOAt (1.2eq); add them to a beaker, take an appropriate amount of DMF, stir to dissolve, add DIPEA (2.0eq), activate the reaction for 3 minutes, and then add it to the peptide solid phase synthesis tube; room temperature 20-35℃, coupling reaction 0.5~1.0 hour; Kaiser method (take a small amount of resin, wash with DMF, add 3-5 drops of ninhydrin solution, heat at 120℃ for 3min; observe whether color appears to determine whether the reaction is complete. If color appears, continue coupling for 0.5 hours); The reaction solution was drained and washed with DMF 3 times (N2 bubbling, 1 min each time, and then drained after washing); According to the amount in the material list, couple the Fmoc-PEG4-propionic acid and Fmoc-HYNIC fragments according to the operation in (2) above; (12) Coupling of Fmoc-PEG4-propionic acid; (13) Coupling of Fmoc-HYNIC; (14) Removal of Fmoc group and color development Add 20% piperidine solution to the peptide solid phase synthesis tube, remove Fmoc twice [N2 bubbling, time (5min, 7min), and drain the liquid after completion], and wash with DMF 6 times (N2 bubbling, 1min each time, and drain after washing); Kaiser method (take a small amount of resin, wash with DMF, add 3-5 drops of ninhydrin solution, heat at 120℃ for 3min, and observe whether color develops) to detect the color change of the resin; (15) Contraction Add appropriate amount of methanol to the peptide solid phase synthesis tube and shrink it 3 times [N2 bubbling, the time is (5min, 5min, 10min), and then drain the liquid after completion]; (16) Drying The mixture was dried under nitrogen flow for 4.0-5.0 hr until the resin particles were no longer sticky and appeared to be in the form of quicksand, to obtain 15.24 g of [CTC-Lys(Boc)-Leu-Arg(Pbf)-Leu-Glu(OtBu)-Trp(Boc)-Asn(Trt)-Arg(Pbf)-PEG4-NH]2Glu-PEG4-HYNIC resin; (17) Cracking Lysis solution preparation: Prepare lysis solution (TFA:TIPS:H2O=95:2.5:2.5v / v) at a ratio of 10ml / 1g resin, mix well, and freeze to 5±5℃; Pre-freeze ether: prepare the required ether according to the ratio of 70ml / 1g resin, freeze it in a freezer for more than 2 hours, and set aside; [CTC-Lys(Boc)-Leu-Arg(Pbf)-Leu-Glu(OtBu)-Trp(Boc)-Asn(Trt)-Arg(Pbf)-PEG4-NH]2Glu-PEG4-HYNIC resin was added to the reaction flask, and the pre-cooled lysate was slowly added under stirring, and the mixture was fully stirred. The lysate was reacted at room temperature of 20-30°C for 2.0-3.0 hours; the mixture was filtered and the filtrate was collected. The filter cake was washed once with a small amount of lysate. The filtrates were combined; ice-cold ether (4-5 ml ether / 1 ml lysate) was added to the reaction flask, and the filtrate was slowly added under stirring to precipitate the product, stirred for 20 minutes, filtered, and fully washed with appropriate amount of ice-cold ether for more than 3 times; the obtained product was vacuum dried at room temperature of 20-30°C for 6.0-7.0 hours to obtain crude HPE(RK)2, the purity of which was 70.420%.
[0109] Preparation of HPE(RK)2 refined products, feed amount: Table 22 Feeding amount for preparing HPE(RK)2 refined product in Example 1
[0110] Process description: The process of preparing HPE(RK)2 refined product is roughly the same as that of preparing HPE(RK)2 in Comparative Example 3, and HPE(RK)2 refined product is obtained with a purification yield of 47.27% and a purity of 99.208%.
[0111] The molecular weight of HPE(RK)2 is 3216.74 (7 molecules of trifluoroacetic acid are removed), and its [M+H] + 、[M / 2+H] + and [M / 3+H] + The molecular weights of the two molecules were 3217.74, 1609.37, and 1073.25, respectively; the molecular weights of the two molecules determined by ESI(+) mass spectrometry were 3217.81, 1609.24, and 1073.22, respectively, which were consistent with the structure of HPE(RK)2.
[0112] Example 2: Preparation of MPE(RK)2 Preparation of crude MPE(RK)2, the structural formula of MAG3 is:
[0113] The structural formula of MPE(RK)2 is:
[0114] Feed amount: about the same as that of the feed amount used to prepare crude HPE(RK)2 in Example 1.
[0115] Table 23 Feeding amount of crude MPE(RK)2 prepared in Example 2
[0116] Process description: The process of preparing crude HPE(RK)2 is roughly the same as that of preparing HPE(RK)2 in Example 1, and [CTC-Lys(Boc)-Leu-Arg(Pbf)-Leu-Glu(OtBu)-Trp(Boc)-Asn(Trt)-Arg(Pbf)-PEG4-NH]2Glu-PEG4-HYNIC resin is obtained; MPE[RK(Dde)]2 crude product is obtained by cleavage, with a crude yield of 113.50% and a purity of 62.011%.
[0117] Preparation of MPE(RK)2 refined product, feed amount: Table 24 Feeding amount for preparing refined MPE(RK)2 in Example 2
[0118] Process description: The process of preparing refined MPE(RK)2 is roughly the same as that of preparing MPE(RK)2 in Example 2, and refined MPE(RK)2 is obtained with a purification yield of 45.98% and a purity of 98.605%.
[0119] Example 3: Preparation of DPE(RK)2 Preparation of crude DPE(RK)2, DOTA-tri-tert-butyl ester has the structural formula:
[0120] The structural formula of DPE(RK)2 is:
[0121] Feed amount: about the same as that of the feed amount used to prepare crude HPE(RK)2 in Example 1.
[0122] Table 25 Feeding amount for preparing crude DPE(RK)2 in Example 3
[0123] Process description: The process of preparing crude HPE(RK)2 is roughly the same as that of preparing HPE(RK)2 in Example 1, and [CTC-Lys(Boc)-Leu-Arg(Pbf)-Leu-Glu(OtBu)-Trp(Boc)-Asn(Trt)-Arg(Pbf)-PEG4-NH]2Glu-PEG4-DOTA(OtBu)3 resin is obtained; DPE(RK)2 crude product is obtained by cleavage, with a crude product yield of 105.82% and a crude product purity of 68.834%.
[0124] Preparation of DPE (RK) 2 refined products, feed amount: Table 26 Feeding amount for preparing refined DPE(RK)2 in Example 3
[0125] Process description: The process of preparing refined MPE(RK)2 is roughly the same as that of preparing MPE(RK)2 in Example 2, and refined DPE(RK)2 is obtained with a purification yield of 44.82% and a purity of 98.463%.
[0126] Example 4: Preparation of NPE(RK)2 Preparation of crude NPE(RK)2, the structural formula of NOTA-di-tert-butyl ester is:
[0127] The structural formula of NPE(RK)2 is:
[0128] Feed amount: approximately the same as that used in Example 1 to prepare crude HPE(RK)2.
[0129] Table 27 Feeding amount for preparing crude NPE(RK)2 in Example 4
[0130] Process description: The process of preparing crude HPE(RK)2 is roughly the same as that of preparing HPE(RK)2 in Example 1, and [CTC-Lys(Boc)-Leu-Arg(Pbf)-Leu-Glu(OtBu)-Trp(Boc)-Asn(Trt)-Arg(Pbf)-PEG4-NH]2Glu-PEG4-NOTA(OtBu)2 resin is obtained; the crude NPE(RK)2 is cracked to obtain a crude product with a crude yield of 104.06% and a purity of 65.774%.
[0131] Preparation of refined NPE(RK)2, feed amount: Table 28 Feeding amount for preparing crude NPE(RK)2 in Example 4
[0132] Process description: The process of preparing refined NPE(RK)2 is roughly the same as that in Comparative Example 4, and the refined NPE(RK)2 is obtained with a purification yield of 46.42% and a purity of 98.867%.
[0133] Table 29 Summary of results of synthesis of chelating agent -PEG4-Glu(RK)2
[0134] It can be seen from the above table that the dimer is prepared by a full solid phase method using the embodiment of the present invention: chelating agent-PEG4-Glu (RK) 2, which avoids the multiple reaction sites existing in the linear polypeptide chain during the liquid phase synthesis process, overcomes the problem of the linear polypeptide chain end carrying carboxyl groups after being cut off from the resin, and makes the dimerization between the relatively difficult macromolecules relatively easy, with a high yield and a simple process, easy operation, and is suitable for industrial production.
[0135] The above description is only a preferred embodiment of the present invention and does not limit the present invention in any form. Any technician familiar with the profession, without departing from the scope of the technical solution of the present invention, according to the technical essence of the present invention, any simple modification, equivalent replacement and improvement made to the above embodiment still falls within the protection scope of the technical solution of the present invention.
Claims
1. A PEG4-H10 dimer, characterized in that: Its structural formula is chelator-PEG4-Glu(RK)2, in which glutamic acid and PEG4 chain form a connecting skeleton; the two carboxyl ends of glutamic acid are coupled with one H10 through a PEG4 chain respectively, so that glutamic acid is coupled with two H10s to form a dimer; the amino end of glutamic acid is coupled to the chelator through a PEG4 chain.
2. The PEG4-H10 dimer according to claim 1, characterized in that: The chelating agent is selected from HYNIC, MAG3, DOTA, NOTA or one of their derivatives.
3. The method for synthesizing the PEG4-H10 dimer according to claim 1 or 2, characterized in that: The following steps are involved: Step (1): First, the following resin structure is obtained by solid phase synthesis: CTC-Lys(Boc)-Leu-Arg(Pbf)-Leu-Glu(OtBu)-Trp(Boc)-Asn(Trt)-Arg(Pbf)-PEG4-NH2 resin, which is represented by CTC-RK; Step (2): Fmoc-Glu-OH and a condensing agent used to activate the two carboxyl groups in Fmoc-Glu-OH are subjected to a dimerization reaction with the CTC-RK obtained in step (1) to obtain the following resin structure: [CTC-Lys(Boc)-Leu-Arg(Pbf)-Leu-Glu(OtBu)-Trp(Boc)-Asn(Trt)-Arg(Pbf)-PEG4-NH]2Glu resin, which is represented by CTC-E(RK)2; Step (3): After the dimerization reaction is completed, the Fmoc group of the product CTC-E(RK)2 is removed, and Fmoc-PEG4-propionic acid and a chelating agent are further coupled by solid phase synthesis to obtain the following resin structure: [CTC-Lys(Boc)-Leu-Arg(Pbf)-Leu-Glu(OtBu)-Trp(Boc)-Asn(Trt)-Arg(Pbf)-PEG4-NH]2Glu-PEG4-chelate resin, which is represented by CTC-chelate-PE(RK)2; Step (4): Finally, the target compound chelator-PEG4-Glu(RK)2 is obtained by cleavage of the peptide from CTC-chelator-PE(RK)2.
4. The method for synthesizing the PEG4-H10 dimer according to claim 3, characterized in that: Step (1) The solid phase synthesis method for preparing CTC-RK is to add HBTU, DIPEA and a to-be-coupled substance to CTC-Lys(Boc), wherein the to-be-coupled substance is a protected amino acid and Fmoc-PEG4-propionic acid, and sequentially couple the protected amino acid and Fmoc-PEG4-propionic acid, and perform a de-Fmoc treatment for each coupling.
5. The method for synthesizing the PEG4-H10 dimer according to claim 4, characterized in that: The protected amino acids include Fmoc-Leu-OH, Fmoc-Arg(Pbf)-OH, Fmoc-Leu-OH, Fmoc-Glu(OtBu)-OH, Fmoc-Trp(Boc)-OH, Fmoc-Asn(Trt)-OH and Fmoc-Arg(Pbf)-OH, and the protected amino acids are coupled in the above order, and finally Fmoc-PEG4-propionic acid is coupled; the reaction molar ratio of CTC-Lys(Boc), protected amino acids or Fmoc-PEG4-propionic acid, HBTU and DIPEA is 1.0:3.0:3.0:3.
0.
6. The method for synthesizing the PEG4-H10 dimer according to claim 4, characterized in that: The synthesis method for preparing CTC-E(RK)2 in step (2) is to add Fmoc-Glu-OH, HATU, HOAt and DIPEA to the CTC-RK obtained in step (1) for reaction, and then perform a de-Fmoc treatment.
7. The method for synthesizing the PEG4-H10 dimer according to claim 6, characterized in that: The reaction molar ratio of CTC-Lys(Boc) in step (1) and Fmoc-Glu-OH, HATU, HOAt, and DIPEA added in step (2) is 1.0:0.5:1.0:1.2:2.
0.
8. The method for synthesizing the PEG4-H10 dimer according to claim 4, characterized in that: The solid phase synthesis method for preparing CTC-chelating agent-PE(RK)2 in step (3) is to add HATU, HOAt, DIPEA and a coupling substance to be coupled to CTC-E(RK)2 obtained in step (2), wherein the coupling substance to be coupled is Fmoc-PEG4-propionic acid and a chelating agent, and sequentially couple Fmoc-PEG4-propionic acid and a chelating agent, and perform a de-Fmoc treatment for each coupling.
9. The method for synthesizing the PEG4-H10 dimer according to claim 8, characterized in that: The reaction molar ratio of CTC-Lys(Boc) in step (1) and Fmoc-PEG4-propionic acid or chelating agent, HATU, HOAt, DIPEA added in step (3) is 1.0:1.5:1.5:1.8:3.
0.
10. The method for synthesizing the PEG4-H10 dimer according to claim 3, characterized in that: In step (4), the CTC resin lysis solution uses 95% TFA lysis solution, which is prepared by TFA:TIPS:H2O=95:2.5:2.5 (v / v), mixed evenly, and frozen to 5±5°C.
